 The Guardian |
Drug Company GlaxoSmithKline Puts American Values to Shame
Huffington Post The asthma drug Advair became a never-ending blockbuster with sales of $7.8 billion in 2010 and predictions that the COPD drug market, which Advair leads, will reach $13.4 billion worldwide in 2020. The success is especially remarkable in regard to the … GlaxoSmithKline pays $3 billion in healthcare fraud settlement State receives $1.7M from largest health-care fraud settlement in US history |
View full post on asthma – Google News